IPO Trending
MONOPHARMASME / NSEListed
Mono Pharmacare

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

₹26 - ₹2813.47x sub
Listed Price₹29.00
Listing Gain+3.57%

IPO Schedule & Timeline

Book Built Issue IPO
Open28 Aug 2023
Close30 Aug 2023
Allotment04 Sep 2023
Listing07 Sep 2023

Quota Reservation & Application Lots

Quota Reservation (% Shares)

Retail22,64,000 shares
42.72%
Nii(hni)22,60,000 shares
42.64%
QIB5,00,000 shares
9.43%
Market Maker2,76,000 shares
5.21%

Minimum Application Lots

Retail1 Lot (4,000 shares)
₹1,12,000
HNI2 Lots (8,000 shares)
₹2,24,000

Company Promoters

Panilam LakhatariyaSupal Lakhatariya

Company Background

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The ...

Lead Managers & Bankers

Financial Performance

Figures in ₹ Crores
Metric Breakdown

Revenue

Latest (Mar 2020)₹1168.9 Cr
Revenue Trend (₹ in Crores)
0.01.4k2.8k4.3kMar 2023Mar 2022Mar 2021Mar 2020
PeriodRev (Cr)PAT (Cr)AssetsDebt
Mar 20201,168.901.99871.70633.46
Mar 20212,837.839.511,122.46608.03
Mar 20223,710.2735.091,438.31643.93
Mar 2023006,257.390

Key Performance Indicators (KPIs)

PeriodEPSROEROCEP/E (Pre)P/E (Post)
Values1.999.01%10.34%040

Broker & Analyst Reviews

Review Not Available

Institutional broker reviews and analyst reports have not been released for this issue yet. Reviews are typically published 2 to 3 days prior to the issue opening date.

IPO Allotment & Registrar Status

Official Registrar: Bigshare Services Private Limited

Allotment Finalized
Allotment Date
04 Sep 2023
Official Status
Out / Finalized
Registrar
Bigshare Services Private Limited
Listing Date
07 Sep 2023

Official Allotment Verification Links

Official Registrar Portal
Bigshare Services Private Limited

Direct allotment verification on the official registrar portal appointed for Mono Pharmacare. Check with PAN or Application No.

Check on Registrar Portal
Stock Exchange Portal
BSE India Investor Portal

Official Bombay Stock Exchange investor verification channel using Issue Name and PAN Number.

Check on BSE India

Allotment Schedule & Milestones

IST
1. Allotment Finalization04 Sep 2023Basis of allotment declared
2. Refund Initiation1 day post allotmentUPI / ASBA mandate unblocked
3. Demat CreditPrior to listingShares credited to CDSL/NSDL
4. Listing Date07 Sep 2023Trading commences on exchange

How to Check Mono Pharmacare Allotment Online

1Open Portal

Click on the official registrar link or BSE portal button above.

2Select Company

Select Mono Pharmacare from the issue drop-down list.

3Enter Details

Select PAN, Application No., or DP Client ID and type your details.

4View Allocation

Click Submit to check your allotted share count and status.

Prospectus & Official Filings

Allotment FAQs & Help

About Mono Pharmacare IPO

Complete issue overview for Mono Pharmacare (MONOPHARMA) IPO. The issue features an equity share price band of ₹26 – ₹28 per share with a minimum retail lot size of 4000 Shares (minimum application amount of ₹1,12,000). Explore live market tracking on our GMP Tracker, compare against All IPO GMP Today, or view category bidding on the Subscription Page. Verify official allotment via IPO Registrars or review participating investment bankers in our Lead Managers Directory.

Frequently Asked Questions